Clinical Trials: The Race to Study Launch and Speed to Finish

DIA ANNUAL MEETING, WASHINGTON DC

PHILADELPHIA and LONDON (JUNE 2, 2010): At this year’s annual meeting, MediciGlobal President and CEO Elizabeth (Liz) Moench will chair and speak at an industry session entitled, Clinical Trials: The Race to Study Launch and Speed to Finish. In an era where CROs and pharmaceutical companies are undertaking ways to speed the process of study launch and accelerating patient recruitment, companies are adopting new processes, technologies and approaches that include market research analysis, team structure and communications, and more. This session will look at the approaches companies and their task forces are undertaking to accelerate study start to achieve an on time or early study finish.

Panelists will also discuss ways different companies are accelerating site and study startup, and ways in which they benchmark their success; Demonstrating how patient recruitment and site feasibility assist in the race to start and the speed to finish the study successfully. The session will conclude with each speaker providing an expert view as to the three essential strategies to expediting study start and accelerating the study to a successful conclusion.

The session will be at the Washington Convention Center on Monday, June 14th from 3:30 p.m. – 5:00 p.m.: Room 146A

Session Chairs:
Elizabeth (Liz) Moench
President and CEO
MediciGlobal Inc.

Presentations & Speakers:
Panelists
Alistair John MacDonald, MS
Executive Vice President, Strategic Development
INC Research, Inc., United States

Peter A. DiBiaso, MHA
Senior Director, Clinical Planning and Performance
Vertex Pharmaceuticals, United States

Christopher H. Cabell, MD,FACC
Senior Vice President, Access to Patients
Quintiles Transnational Corp., United States

###

About MediciGlobal
MediciGlobal is in the business of making a meaningful difference to patient health—by identifying and engaging patients for clinical trials, and by building deep and lasting connections with our many stakeholders. Our clinical trial recruitment practices are guided by global standards and by our concern for the lives of the patients who put their trust in us. We’re also making certain that those who participate in these trials fully understand what clinical trial participation means, and that their participation is guarded by strict privacy policies. MediciGlobal meets BBB OnLine® and WBENC accreditation standards and is certified as a Safe Harbor company. Visit www.mediciglobal.com and follow the company on Facebook at www.facebook.com/MediciGlobal. www.mediciglobal.com

For further information contact:
Alicia Carango
+1 484-674-6855
acarango@MediciGlobal.com